Stanislav Svetlov
chief scientific officer
Immunova, LLC, Medicine, University of Florida
USA
Biography
Dr. Svetlov has expertise and international recognition for studies of traumatic brain injury (TBI), especially combat-related blast TBI proven by a number of publications and awards from Department of Defense on molecular signatures and biomarkers of blast brain injury and US patents. The goal is to determine and characterize biomarkers reflecting chronic encephalopathy, including neuroinflammation and impaired neurogenesis and repair. Dr. Svetlov is a chief scientific officer at Immunova, LLC, a biopharmaceutical company fully licensed Dr. Svetlov technology and adjunct research associate professor at UF Medicine/Psychiatry
Research Interest
neuroinflammation and impaired neurogenesis and repair